PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-60

  1. 905 Posts.
    lightbulb Created with Sketch. 277
    Sounds to me when you get your shots proper they will be life changing (for the better)!

    Hang in there. Ignore the price action today, it’s all calculated.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.